A Unique Presentation of 3-Methylcrotonyl-CoA Carboxylase Deficiency
Ashwin Jagadish1, Kaitlin Sclater1, Taylor Lapinski1
1Pediatrics, East Tennessee State University James H. Quillen College of Medicine, Johnson City, USA.
Abstract:
3-methylcrotonyl-CoA carboxylase deficiency is an autosomal recessive disorder resulting in impaired leucine metabolism. The condition is typically diagnosed with newborn screening; patients diagnosed at a later stage generally present with symptoms including metabolic disturbances, seizures, failure to thrive, or delayed development. We present the case of a child diagnosed at 12 months of age who was noted to have recurrent viral infections and nonspecific gastrointestinal symptoms of vomiting, hematochezia, and gaseous distention of the abdomen. Newborn screening did not reveal any abnormalities. Evaluation for underlying immunodeficiency was unremarkable; genetic testing revealed bi-allelic mutations in MCCC2, a known association of 3-methylcrotonyl-CoA carboxylase deficiency. It is important to consider genetic disorders when evaluating patients even if the newborn screening is unremarkable.
Related Concept Videos
Inborn Errors of Metabolism
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
Loss of Carboxy Group as CO2: Decarboxylation of β-Ketoacids
Amino Acid Catabolism
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
Animal Mitochondrial Genetics


